788331007: Product containing polatuzumab vedotin in parenteral dose form (medicinal product form)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Mitotic inhibitor-containing product\Microtubule inhibitor-containing product\Polatuzumab vedotin-containing product\Polatuzumab vedotin-containing product in parenteral dose form
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Polatuzumab vedotin-containing product\Polatuzumab vedotin-containing product in parenteral dose form
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\Monoclonal antibody antineoplastic agent\Polatuzumab vedotin-containing product\Polatuzumab vedotin-containing product in parenteral dose form
• \Product manufactured as parenteral dose form\Polatuzumab vedotin-containing product in parenteral dose form

Status: current, Defined. Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3779942015	Product containing polatuzumab vedotin in parenteral dose form (medicinal product form)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
3779943013	Polatuzumab vedotin-containing product in parenteral dose form	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start